載入...
Perforation of the Colon During Imatinib Mesylate (Gleevec) Treatment in a Patient with Chronic Myeloid Leukemia (CML)
Imatinib (Gleevec; STI-571) is a tyrosine-kinase inhibitor (TKI) used in the treatment of multiple cancers, most notably Philadelphia chromosome-positive (Ph+) chronic myelogenous leukemia (CML) as well as gastrointestinal stromal tumor (GIST). The most common adverse effects with imatinib include s...
Na minha lista:
| 發表在: | Cureus |
|---|---|
| Main Authors: | , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Cureus
2016
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4963232/ https://ncbi.nlm.nih.gov/pubmed/27489753 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7759/cureus.660 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|